SPDR SER TR - S&P BIOTECH (XBI)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / S&P BIOTECH
Shares, excl. options Q1 2024
90.2 M
Holdings value Q1 2024
$8.56 B
Value change Q1 2024
+$1.24 B
Grand Portfolio weight change Q1 2024
+0.003%
Number of holders
744
Number of buys Q1 2024
360
Number of sells Q1 2024
-305
Average buys Q1 2024 %
+0.602%
Average sells Q1 2024 %
-0.006%
CUSIP
78464A870
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 90.2 M $8.56 B +$1.24 B $94.89 744
2023 Q4 77.3 M $6.91 B -$168 M $89.29 742
2023 Q3 80.3 M $5.86 B +$330 M $73.02 675
2023 Q2 83.1 M $6.91 B -$900 M $83.20 704
2023 Q1 92.4 M $7.04 B +$187 M $76.21 705
2022 Q4 91.2 M $7.56 B +$1.15 B $83.00 730
2022 Q3 78.3 M $6.21 B -$199 M $79.32 694
2022 Q2 80.6 M $5.99 B +$546 M $74.27 698
2022 Q1 73 M $6.56 B +$661 M $89.88 698
2021 Q4 65.4 M $7.32 B +$817 M $111.96 702
2021 Q3 56.7 M $7.13 B -$429 M $125.71 639
2021 Q2 60.5 M $8.19 B -$2.2 B $135.40 672
2021 Q1 76.5 M $10.4 B -$1.17 B $135.65 644
2020 Q4 84.8 M $11.9 B +$1.34 B $140.78 651
2020 Q3 75.5 M $8.42 B -$24.2 M $111.43 562
2020 Q2 75.9 M $8.5 B -$1.09 B $111.95 536
2020 Q1 86 M $6.66 B +$1.58 B $77.44 438
2019 Q4 64.5 M $6.13 B +$141 M $95.11 492
2019 Q3 59.6 M $4.55 B +$153 M $76.25 419
2019 Q2 57.3 M $5.02 B -$555 M $87.71 438
2019 Q1 63.7 M $5.77 B +$548 M $90.54 461
2018 Q4 58.1 M $4.17 B +$31.3 M $71.75 436
2018 Q3 56 M $5.37 B -$127 M $95.87 453
2018 Q2 57.1 M $5.44 B +$168 M $95.19 448
2018 Q1 58.4 M $5.12 B +$1.14 B $87.73 428
2017 Q4 45.7 M $3.88 B +$137 M $84.87 415
2017 Q3 43.5 M $3.76 B -$258 M $86.57 371
2017 Q2 46.5 M $3.59 B +$166 M $77.18 328
2017 Q1 44.6 M $3.09 B +$590 M $69.34 307
2016 Q4 36.6 M $2.17 B -$634 M $59.19 286
2016 Q3 47 M $3.11 B +$342 M $66.29 242
2016 Q2 42.7 M $2.31 B -$119 M $54.08 218
2016 Q1 44.4 M $2.29 B +$44.6 M $51.66 209
2015 Q4 43.4 M $3.04 B -$591 M $70.20 202
2015 Q3 52.2 M $3.25 B +$2.24 B $62.25 215
2015 Q2 15.7 M $3.95 B +$870 M $252.24 215
2015 Q1 12.2 M $2.76 B +$194 M $225.50 193
2014 Q4 11.6 M $2.16 B +$134 M $186.47 150
2014 Q3 10.8 M $1.68 B +$65.5 M $155.97 132
2014 Q2 10.4 M $1.6 B -$146 M $153.99 127
2014 Q1 11.4 M $1.62 B +$285 M $142.48 136